Search

everythinglearnresearchcommunity

for

Search:↓

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Photodynamic therapy can remove nonpigmented hair in mice and might work for humans.

Home-use medical-cosmetic devices like lasers for hair removal may be convenient but need more research to confirm safety and effectiveness.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Early diagnosis and treatment can reduce cicatricial alopecia in middle-aged individuals, especially females.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Hair loss might be an early sign of Hodgkin disease.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Bullous pyoderma gangrenosum can develop on cesarean scars and may require steroids for treatment.

Thyroid receptor β can help develop new drugs to treat hair loss.

Tofacitinib helped a woman regrow hair with no major side effects.